Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils

Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils

Animal models that accurately recapitulate the accumulation of alpha-synuclein (α-syn) inclusions, progressive neurodegeneration of the nigrostriatal system and motor deficits can be useful tools for Parkinson's disease (PD) research. The preformed fibril (PFF) synucleinopathy model in rodents...

Full description

Bibliographic Details
Main Authors:	Joseph R. Patterson, Megan F. Duffy, Christopher J. Kemp, Jacob W. Howe, Timothy J. Collier, Anna C. Stoll, Kathryn M. Miller, Pooja Patel, Nathan Levine, Darren J. Moore, Kelvin C. Luk, Sheila M. Fleming, Nicholas M. Kanaan, Katrina L. Paumier, Omar M.A. El-Agnaf, Caryl E. Sortwell
Format:	Article
Language:	English
Published:	Elsevier 2019-10-01
Series:	Neurobiology of Disease
Subjects:	Alpha-Synuclein Preformed fibrils Synucleinopathy Parkinson's disease
Online Access:	http://www.sciencedirect.com/science/article/pii/S0969996119301937

Similar Items

Quality Over Quantity: Advantages of Using Alpha-Synuclein Preformed Fibril Triggered Synucleinopathy to Model Idiopathic Parkinson’s Disease
by: Megan F. Duffy, et al.
Published: (2018-09-01)

Leveraging the preformed fibril model to distinguish between alpha-synuclein inclusion- and nigrostriatal degeneration-associated immunogenicity
by: Anna C. Stoll, et al.
Published: (2022-09-01)

Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
by: Megan F. Duffy, et al.
Published: (2018-05-01)

The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
by: Jacob S. Deyell, et al.
Published: (2023-01-01)

α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies
by: Matthias Schmitz, et al.
Published: (2023-03-01)

In Silico Evaluation of the Potential Association of the Pathogenic Mutations of Alpha Synuclein Protein with Induction of Synucleinopathies
by: Mohamed E. Elnageeb, et al.
Published: (2023-09-01)

Cerebral Microvascular Injury Induced by Lag3‐Dependent α‐Synuclein Fibril Endocytosis Exacerbates Cognitive Impairment in a Mouse Model of α‐Synucleinopathies
by: Qingxi Zhang, et al.
Published: (2023-09-01)

α-Synuclein Strains: Does Amyloid Conformation Explain the Heterogeneity of Synucleinopathies?
by: Simon Oliver Hoppe, et al.
Published: (2021-06-01)

Possible Alterations in β-Synuclein, the Non-Amyloidogenic Homologue of α-Synuclein, during Progression of Sporadic α-Synucleinopathies
by: Makoto Hashimoto, et al.
Published: (2012-09-01)

Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies
by: Chao Peng, et al.
Published: (2018-01-01)

Reciprocal effects of alpha-synuclein aggregation and lysosomal homeostasis in synucleinopathy models
by: Alice Drobny, et al.
Published: (2023-06-01)

Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
by: Hao Gu, et al.
Published: (2021-03-01)

Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
by: Ichiro Kawahata, et al.
Published: (2022-06-01)

Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies
by: Mie Kristine Just, et al.
Published: (2022-05-01)

Biochemical Fractionation of Human α-Synuclein in a <i>Drosophila</i> Model of Synucleinopathies
by: Khondamir Imomnazarov, et al.
Published: (2024-03-01)

Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
by: Jacqui T. Nimmo, et al.
Published: (2020-11-01)

Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies
by: Akio Sekigawa, et al.
Published: (2015-05-01)

Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
by: Yaping Chu, et al.
Published: (2007-01-01)

Intrastriatal injection of α-synuclein can lead to widespread synucleinopathy independent of neuroanatomic connectivity
by: Zachary A. Sorrentino, et al.
Published: (2017-05-01)

Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies
by: Juan Huang, et al.
Published: (2024-03-01)

Preclinical Detection of Alpha-Synuclein Seeding Activity in the Colon of a Transgenic Mouse Model of Synucleinopathy by RT-QuIC
by: Jung-Youn Han, et al.
Published: (2021-04-01)

Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
by: Elisabet Jakova, et al.
Published: (2022-02-01)

PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats
by: Majken B. Thomsen, et al.
Published: (2021-02-01)

RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies
by: Ilaria Poggiolini, et al.
Published: (2021-05-01)

A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy
by: Karima Schwab, et al.
Published: (2018-01-01)

Alpha-Synuclein Preformed Fibrils Induce Cellular Senescence in Parkinson’s Disease Models
by: Dinesh Kumar Verma, et al.
Published: (2021-07-01)

A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy
by: Mali Cosden, et al.
Published: (2021-11-01)

Structural and Functional Insights into α-Synuclein Fibril Polymorphism
by: Surabhi Mehra, et al.
Published: (2021-09-01)

Revisiting Alpha-Synuclein Pathways to Inflammation
by: Patrícia Lyra, et al.
Published: (2023-04-01)

Monitoring α-synuclein aggregation
by: Juan Estaun-Panzano, et al.
Published: (2023-01-01)

Time-dependent alterations in the rat nigrostriatal system after intrastriatal injection of fibrils formed by α–Syn and tau fragments
by: Xiaoman Yang, et al.
Published: (2022-11-01)

Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
by: Allison J. Schaser, et al.
Published: (2020-08-01)

Mechanism of Anti-α-Synuclein Immunotherapy
by: Jun Sung Lee, et al.
Published: (2016-01-01)

Effect of the Fibre Orientation Distribution on the Mechanical and Preforming Behaviour of Nonwoven Preform Made of Recycled Carbon Fibres
by: Jean Ivars, et al.
Published: (2021-12-01)

Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrils
by: Joseph R. Patterson, et al.
Published: (2024-01-01)

Inflammation kinase PKR phosphorylates α-synuclein and causes α-synuclein-dependent cell death
by: Lasse Reimer, et al.
Published: (2018-07-01)

Fishing for synucleinopathy models
by: Suzita Mohd Noor, et al.
Published: (2022-03-01)

Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapy
by: Julia E. Gerson, et al.
Published: (2018-03-01)

Production of Recombinant Alpha-Synuclein: Still No Standardized Protocol in Sight
by: Mohammed Al-Azzani, et al.
Published: (2022-02-01)

Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease
by: Scott G. Allen, et al.
Published: (2023-11-01)